Nervgen Pharma Corp.
NGEN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001751912
No open-market purchases or sales by Nervgen Pharma Corp. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $24.9M in total; no superinvestor holds it.
Superinvestors holding NGEN, Q2 2026
No superinvestor reported holding NGEN in Q2 2026.